In May, 2019 a drug, Zolgensma by Novartis will enter the US market with a price of over $2M. The drug is used to treat Spinal Muscular Atrophy which is fatal before age 2. https://www.beckershospitalreview.com/pharmacy/novartis-pegs-it-s-spinal-muscular-atrophy-drug-at-4m.html

ORDER NOW